Table 1.
Summary of characteristics
| Characteristics | PDAC, % (n) | Control, % (n) |
|---|---|---|
| Age, years | ||
| ≤39 | 0 (0) | 7.8 (4) |
| 40–49 | 4.3 (1) | 11.7 (6) |
| 50–59 | 4.3 (1) | 9.8 (5) |
| 60–69 | 26.0 (6) | 41.2 (21) |
| 70–79 | 56.5 (13) | 13.7 (7) |
| ≥80 | 8.7 (2) | 15.7 (8) |
| Gender | ||
| Male | 52.2 (12) | 43.1 (22) |
| Female | 47.8 (11) | 56.9 (29) |
| Diagnosed with diabetes | ||
| Yes | 21.7 (5) | 13.7 (7) |
| No | 78.3 (18) | 86.3 (44) |
| Diagnosed with hypertension | ||
| Yes | 43.5 (10) | 37.3 (19) |
| No | 56.5 (13) | 62.7 (32) |
| Serum uric acid | ||
| Upregulated | 13.0 (3) | 17.6 (9) |
| Normal range | 87.0 (20) | 82.4 (42) |
| Serum triglyceride | ||
| Upregulated | 8.7 (2) | 31.4 (16) |
| Normal range | 91.3 (21) | 68.6 (35) |
| Stagea | ||
| 0 | 4.3 (1) | |
| IA | 0 (0) | |
| IB | 0 (0) | |
| IIA | 8.7 (2) | |
| IIB | 17.4 (4) | |
| III | 26.1 (6) | |
| IV | 43.5 (10) | |
| Serum CA19-9, median (IQR) | 75.6 (13.4–306.5) | 12.7 (0.93–28.4) |
Note:
a
Classified according to the classification of the International Union against Cancer.
Abbreviations: CA19-9, cancer antigen 19-9; IQR, interquartile range; PDAC, pancreatic ductal adenocarcinoma.